DK2276850T5 - Irx-2-modificeret fremstillingsfremgangsmåde - Google Patents

Irx-2-modificeret fremstillingsfremgangsmåde

Info

Publication number
DK2276850T5
DK2276850T5 DK09743225.6T DK09743225T DK2276850T5 DK 2276850 T5 DK2276850 T5 DK 2276850T5 DK 09743225 T DK09743225 T DK 09743225T DK 2276850 T5 DK2276850 T5 DK 2276850T5
Authority
DK
Denmark
Prior art keywords
irx
preparation procedure
modified preparation
modified
procedure
Prior art date
Application number
DK09743225.6T
Other languages
English (en)
Other versions
DK2276850T3 (da
Inventor
George J Fennington
Harvey J Brandwein
Original Assignee
Irx Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Irx Therapeutics Inc filed Critical Irx Therapeutics Inc
Publication of DK2276850T3 publication Critical patent/DK2276850T3/da
Application granted granted Critical
Publication of DK2276850T5 publication Critical patent/DK2276850T5/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DK09743225.6T 2008-04-14 2009-04-14 Irx-2-modificeret fremstillingsfremgangsmåde DK2276850T5 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4467408P 2008-04-14 2008-04-14
PCT/US2009/040511 WO2009137238A2 (en) 2008-04-14 2009-04-14 Irx-2 modified manufacturing process

Publications (2)

Publication Number Publication Date
DK2276850T3 DK2276850T3 (da) 2013-10-07
DK2276850T5 true DK2276850T5 (da) 2013-12-02

Family

ID=41164313

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09743225.6T DK2276850T5 (da) 2008-04-14 2009-04-14 Irx-2-modificeret fremstillingsfremgangsmåde

Country Status (9)

Country Link
US (1) US8470562B2 (da)
EP (1) EP2276850B9 (da)
JP (1) JP5647601B2 (da)
AU (1) AU2009244617B2 (da)
CA (1) CA2758834C (da)
DK (1) DK2276850T5 (da)
ES (1) ES2430389T3 (da)
MX (1) MX2010011179A (da)
WO (1) WO2009137238A2 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070025958A1 (en) 2000-10-27 2007-02-01 Hadden John W Vaccine immunotherapy
US20070154399A1 (en) * 2000-10-27 2007-07-05 Hadden John W Immunotherapy for immune suppressed patients
CA2950109C (en) 2000-10-27 2019-02-19 John W. Hadden Vaccine immunotherapy for immune suppressed patients
AU2008329741B2 (en) 2007-11-28 2013-09-12 Irx Therapeutics, Inc. Method of increasing immunological effect
WO2010132867A1 (en) 2009-05-15 2010-11-18 Irx Therapeutics, Inc. Vaccine immunotherapy
US9333238B2 (en) 2009-12-08 2016-05-10 Irx Therapeutics, Inc. Method of immunotherapy for treament of human papillomavirus infection

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7025A (en) * 1850-01-15 Buckle
US4390623A (en) * 1980-10-02 1983-06-28 Hooper Trading Company Serum-free and mitogen-free T-cell growth factor and process for making same
US6534055B1 (en) * 1988-11-23 2003-03-18 Genetics Institute, Inc. Methods for selectively stimulating proliferation of T cells
DE9390311U1 (de) * 1993-05-18 1996-05-09 I.D.M. Immuno-Designed Molecules, Paris Neue Makrophagen mit Eignung als Wirkstoffe von pharmazeutischen Zusammensetzungen
DK0789588T3 (da) * 1994-11-17 2005-05-30 Univ South Florida Metode til fremstilling af et medikament til behandling af sekundær immundefekt
US7220557B2 (en) * 1997-04-24 2007-05-22 Human Genome Sciences, Inc. METH1 polynucleotides
IL151287A0 (en) * 2000-02-24 2003-04-10 Xcyte Therapies Inc A method for stimulation and concentrating cells
US20070025958A1 (en) * 2000-10-27 2007-02-01 Hadden John W Vaccine immunotherapy
US20060194242A1 (en) * 2000-10-27 2006-08-31 Hadden John W Immunotherapy for immune suppressed patients
CA2950109C (en) * 2000-10-27 2019-02-19 John W. Hadden Vaccine immunotherapy for immune suppressed patients
DK1337280T3 (da) * 2000-11-13 2013-12-02 Bayer Ip Gmbh Fremgangsmåde til inaktivering af mikroorganismer i en fluid ved anvendelse af ultraviolet stråling
US20060165667A1 (en) * 2004-12-03 2006-07-27 Case Western Reserve University Novel methods, compositions and devices for inducing neovascularization
WO2007067782A2 (en) * 2005-12-08 2007-06-14 Northwest Biotherapeutics, Inc. Compositions and methods for inducing the activation of immature monocytic dendritic cells
WO2007130826A2 (en) * 2006-05-04 2007-11-15 Ge Healthcare Bio-Sciences Ab Separation of cells

Also Published As

Publication number Publication date
ES2430389T9 (es) 2014-02-06
EP2276850A4 (en) 2012-02-29
EP2276850B9 (en) 2013-10-30
EP2276850B1 (en) 2013-07-31
ES2430389T3 (es) 2013-11-20
JP5647601B2 (ja) 2015-01-07
MX2010011179A (es) 2010-12-06
WO2009137238A3 (en) 2010-01-14
US20090258395A1 (en) 2009-10-15
EP2276850A2 (en) 2011-01-26
JP2011516582A (ja) 2011-05-26
DK2276850T3 (da) 2013-10-07
CA2758834C (en) 2017-11-07
WO2009137238A2 (en) 2009-11-12
US8470562B2 (en) 2013-06-25
AU2009244617B2 (en) 2014-02-13
CA2758834A1 (en) 2009-11-12
AU2009244617A1 (en) 2009-11-12

Similar Documents

Publication Publication Date Title
DK2370462T3 (da) Glucagon-analoger
BRPI0907376A2 (pt) Fotobiorretador
DK2342317T3 (da) Hængende-dråbe-plade
DE602009000234D1 (de) msignals
DK3444343T3 (da) Polypeptider
BRPI0914743A2 (pt) estrutura
DE602008003972D1 (de) Sitzrücklehnungsmechanismus
DE602008003521D1 (de) Sitzrücklehnungsmechanismus
DK2335031T3 (da) In-line-måler
DK2125048T3 (da) Præparat
DK2837348T3 (da) Kryokirurgiske fremgangsmåder
DK2379557T3 (da) Aminopyrazol-forbindelse
DE602008003970D1 (de) Strahlstromkalibriersystem
DK2271613T3 (da) Hydroxymethylcyklohexylaminer
BRPI0907522A2 (pt) biarlamidas
BRPI0909634A2 (pt) 2-aminoquinolinas
DE112009000183A5 (de) Sicherheitsvorreiber
DE112009001946A5 (de) Mobelauszugsführung
DE602009000488D1 (de) Obstvereinzelvorrichtung
BRPI0907863A2 (pt) pirrolopirimidinacarboxamidas
DE602009000862D1 (de) Gehwagenbremse
DK2344933T3 (da) Uretui
AT507449A3 (de) Dämmstoffbefestiger
FI20085899A0 (fi) Puu-Metalli-komposiittirakenne
DK2276850T5 (da) Irx-2-modificeret fremstillingsfremgangsmåde